Business Context and Reporting Period
Purple Innovation, Inc. (PRPL) filed this Form 8-K on February 8, 2023, to report the entry into a material definitive agreement for an underwritten public offering of its Class A common stock. The company is incorporated in Delaware and headquartered in Lehi, Utah.
Key Financial Metrics and Transaction Details
- Public Offering Size: 13,400,000 shares of Class A common stock, plus an over-allotment option for 2,010,000 shares.
- Offering Price: $4.50 per share to the public; $4.275 per share to the underwriters.
- Net Proceeds (Public Offering): Approximately $57.0 million after estimated offering expenses.
- Coliseum Private Placement: A concurrent private placement with Coliseum Capital Management (holding ~44.48% voting power) for up to 1,610,317 shares at $4.50 per share, contingent on the over-allotment option being exercised.
- Net Proceeds (Private Placement): Estimated at approximately $7.2 million if fully subscribed.
- Underwriters: BMO Capital Markets Corp. and KeyBanc Capital Markets Inc.
- Expected Closing Date: On or about February 13, 2023.
Material Changes and Agreements
The primary material change is the execution of the Underwriting Agreement dated February 8, 2023. This agreement includes a 60-day lock-up provision preventing the Company, its directors, and executive officers from selling or transferring Class A common stock or related securities, subject to limited exceptions. Additionally, the Company agreed to a concurrent private placement with Coliseum Capital Management to maintain their pro rata ownership interest if the over-allotment option is exercised.
Outlook, Risks, and Management Commentary
The filing contains forward-looking statements regarding the anticipated closing of the Offering and the Coliseum Private Placement. Management notes that these events are subject to customary closing conditions and risks beyond the Company's control. The filing explicitly disclaims any obligation to update forward-looking statements. Investors are directed to the "Risk Factors" section of the Company's Annual Report on Form 10-K (filed March 1, 2022) for a detailed discussion of risks.
Key Facts for Investor Verification
- Verify the final closing date of the offering, currently expected to be February 13, 2023.
- Confirm whether the underwriters exercise the over-allotment option for the additional 2,010,000 shares.
- Monitor the actual net proceeds received, as the $57.0 million and $7.2 million figures are estimates subject to final expenses and option exercise.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific representations, warranties, and indemnification terms.
- Check subsequent filings for any updates on the satisfaction of closing conditions.